Despite Record Earnings by Samsung Electronics, KOSPI Starts Lower

Foreign Investors Continue to Sell
Samsung Electronics Shares Drop Over 5%

The KOSPI started lower in early trading on July 7. The KOSDAQ is fluctuating around the flatline.

As of 9:19 a.m. on this day at the Korea Exchange, the KOSPI was trading at 7,797.55, down 253.78 points (3.15%) from the previous session.

Sell-offs by foreign investors and institutions led to the decline in the index. While individual investors are net buyers with 384.7 billion won, foreign investors are net sellers of 346.3 billion won, and institutions are net sellers of 30 billion won.

On the 7th, as the KOSPI index plunged nearly 4% in early trading and fell below the 8,000 level, the status of the domestic stock market was displayed on the electronic board at the Hana Bank dealing room in Jung-gu, Seoul. 2026.7.7 Photo by Kang Jinhyung

Most sectors are also declining. Transportation equipment and parts (-6.49%), machinery and equipment (-3.46%), electrical and electronics (-3.16%), securities (-2.86%), construction (-2.77%), metals (-2.73%), and electricity and gas (-2.47%) all fell. Meanwhile, food, beverage and tobacco (1.31%), and medical and precision instruments (1.14%) rose.

Major large-cap stocks are also showing declines. Hanwha Ocean, which failed to win the Canadian submarine contract, dropped 21.5%. Even Samsung Electronics, which posted record earnings, is down 5.3%. Other losers include Hanwha Aerospace (down 7.5%), Hyundai Rotem (down 5.9%), HD Hyundai Heavy Industries (down 5.6%), SK Square (down 4.7%), and Samsung Life Insurance (down 4.6%).

At the same time, the KOSDAQ was trading at 852.86, up 5.79 points (0.68%) from the previous session. After initially declining, it has rebounded to an upward trend.

Individual investors are net sellers of 67.7 billion won, while foreign investors and institutions are net buyers of 11.1 billion won and 58.5 billion won, respectively.

Most major large-cap stocks on the KOSDAQ are rising. D&D Pharmatech surged 15.5%, with PharmaResearch (12.1%), LIG ChemBio (11.2%), Caregen (9.6%), Olix (8.2%), ABL Bio (7.7%), and PSK Holdings (7.3%) also posting gains.

This content was produced with the assistance of AI translation services.